Celgene Looks to Build Critical Mass in Inflammation and Immunology via US$7.2 B Receptos Acquisition
By Heather Cartwright & Smita Mishra
Pharma Deals Review: Vol 2015 Issue 8 (Table of Contents)
Published: 12 Aug-2015
DOI: 10.3833/pdr.v2015.i8.2116 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a deal that will enhance its burgeoning Inflammation and Immunology portfolio, Celgene has agreed to acquire Receptos for a purchase price of approximately US$7...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS